Literature DB >> 19930448

Paraoxonase gene polymorphisms and stroke severity.

L Lazaros1, S Markoula, A Kyritsis, I Georgiou.   

Abstract

BACKGROUND: Paraoxonase (PON) is an HDL-associated enzyme that prevents low-density lipoprotein oxidation, playing a major role in the pathogenesis of atherosclerosis. PON genes polymorphisms may affect the corresponding enzyme activity. In this study, we examined the association of ischemic stroke with the three PON genes.
METHODS: One hundred and seventy-eight patients hospitalized for ischemic stroke and 181 age- and sex-matched healthy controls were recruited. PON1(Q/R) 192, PON1(M/L) 55, and PON2(S/C) 311 polymorphisms were analyzed.
RESULTS: The presence of the PON2 311C allele was significantly increased in patients with severe forms of ischemic stroke according to Modified Rankin Scale (P = 0.02, odds ratio = 2.215). No significant differences in genotype and allele distribution were observed between patients and controls.
CONCLUSIONS: The PON2 311C allele was suggested as a possible predisposing factor for severe cases of ischemic stroke. Large-scale multicenter-controlled prospective studies are warranted to further explore the effects of PON polymorphisms on stroke susceptibility and severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19930448     DOI: 10.1111/j.1468-1331.2009.02860.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing-Cheng Li
Journal:  Mol Biol Rep       Date:  2011-12-20       Impact factor: 2.316

Review 2.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

3.  PON2 and ATP2B2 gene polymorphisms with noise-induced hearing loss.

Authors:  Xiuting Li; Jinglian Cao; Jun Wang; Haiyan Song; Guixiang Ji; Qiu Dong; Chunlong Wei; Ying Cao; Boshen Wang; Baoli Zhu; Hang Xiao
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

4.  Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population.

Authors:  Zhiyao Wang; Yanqiong Zhang; Xiangying Kong; Shangzhu Li; Yimin Hu; Rongtian Wang; Yan Li; Chao Lu; Na Lin; Weiheng Chen
Journal:  Diagn Pathol       Date:  2013-11-08       Impact factor: 2.644

Review 5.  Human paraoxonase 2.

Authors:  Sureerut Porntadavity; Thinnakorn Permpongpaiboon; Wanida Sukketsiri
Journal:  EXCLI J       Date:  2010-11-26       Impact factor: 4.068

6.  The Association of PON1 192 Q/R Polymorphism with the Risk of Idiopathic Male Infertility in Northern Iran.

Authors:  Setareh Behrouzi; Farhad Mashayekhi; Mohammad Hadi Bahadori
Journal:  Avicenna J Med Biotechnol       Date:  2018 Oct-Dec

7.  Women's prepregnancy lipid levels and number of children: a Norwegian prospective population-based cohort study.

Authors:  Aleksandra Pirnat; Lisa A DeRoo; Rolv Skjærven; Nils-Halvdan Morken
Journal:  BMJ Open       Date:  2018-07-09       Impact factor: 2.692

8.  WTAP and BIRC3 are involved in the posttranscriptional mechanisms that impact on the expression and activity of the human lactonase PON2.

Authors:  Teresa Maria Carusone; Giovanna Cardiero; Mariangela Cerreta; Luigi Mandrich; Oscar Moran; Elena Porzio; Giuliana Catara; Giuseppina Lacerra; Giuseppe Manco
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 8.469

9.  DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress.

Authors:  Mohammad Parsanejad; Noam Bourquard; Dianbo Qu; Yi Zhang; En Huang; Maxime W C Rousseaux; Hossein Aleyasin; Isabella Irrcher; Steve Callaghan; Dominique C Vaillant; Raymond H Kim; Ruth S Slack; Tak W Mak; Srinivasa T Reddy; Daniel Figeys; David S Park
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.